The use of mood stabilizers during breastfeeding

Journal of Clinical Psychiatry

Volumn 68, Issue SUPPL. 9, 2007, Pages 22-28

  Stowe, Zachary N ^a,b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; ARIPIPRAZOLE; ATYPICAL ANTIPSYCHOTIC AGENT; CARBAMAZEPINE; CITALOPRAM; CLOZAPINE; FLUOXETINE; FOLIC ACID; LAMOTRIGINE; LITHIUM; LITHIUM CARBONATE; METOCLOPRAMIDE; MOOD STABILIZER; NEUROLEPTIC AGENT; OLANZAPINE; OXCARBAZEPINE; PAROXETINE; PSYCHOTROPIC AGENT; QUETIAPINE; RISPERIDONE; SERTRALINE; TOPIRAMATE; VALPROIC ACID; ZIPRASIDONE;

BIPOLAR DISORDER; BLOOD CELL COUNT; BREAST FEEDING; COLIC; DRUG EXPOSURE; GLUCOSE BLOOD LEVEL; HUMAN; MENTAL HEALTH; NURSING; ORGANIZATION; PATIENT MONITORING; PRACTICE GUIDELINE; PREGNANCY; PRIORITY JOURNAL; PUERPERIUM; RASH; REVIEW; RIGIDITY; RISK BENEFIT ANALYSIS; SIDE EFFECT; THROMBOCYTE; THYROTROPIN BLOOD LEVEL; TREATMENT PLANNING; UNSPECIFIED SIDE EFFECT; UREA NITROGEN BLOOD LEVEL; WEIGHT; DRUG CONTRAINDICATION; FEMALE; INFANT; MENTAL DISEASE; NEWBORN; PSYCHOLOGICAL ASPECT; RISK FACTOR;

BREAST FEEDING; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MENTAL DISORDERS; POSTPARTUM PERIOD; PSYCHOTROPIC DRUGS; RISK FACTORS;

EID: 35348941891     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (73)

1. Nichols-Johnson V. Promoting breastfeeding as an obstetrician/ gynecologist. Clin Obstet Gynecol 2004;47:624-631
2. Altshuler LL, Cohen L, Szuba MP, et al. Pharmacologic management of psychiatric illness during pregnancy: dilemmas and guidelines. Am J Psychiatry 1996;153:592-606
3. American Academy of Pediatrics Committee on Drugs. The transfer of drugs and other chemicals into human milk. Pediatrics 2001;108:776-1029
4. Committee on Health Care for Underserved Women. Breastfeeding: maternal and infant aspects. Int J Gynaecol Obstet 2001;74:217-232
5. American Dietetic Association. Position of the American Dietetic Association: breaking the barriers to breastfeeding. J Am Diet Assoc 2001;101:1213-1220
6. Ryan AS, Wenjun Z, Acosta A. Breastfeeding continues to increase into the new millennium. Pediatrics 2002;110:1103-1109
7. Kendell RE, Chalmers JC, Platz C. Epidemiology of puerperal psychosis. Br J Psychiatry 1987;150:662-673
8. Spencer JP, Gonzalez LS, Barnhart DJ. Medications in breast-feeding mother. Am Fam Physician 2001;64:119-129
9. Hale TW. Medications and Mother's Milk: A Manual of Lactational Pharmacology. 11th ed. Amarillo, Tex: Pharmasoft Publishing; 2004
10. Yoshida K, Smith B, Kumar R. Psychotropic drugs in mother's milk: a comprehensive review of assay methods, pharmacokinetics and of safety of breast-feeding. J Psychopharmacol 1999;13:64-80
11. Ilett KF, Kristensen JH, Hackett LP, et al. Distribution of venlafaxine and its O-desmethyl metabolite in human milk and their effects in breastfed infants. Br J Clin Pharmacol 2002;53:17-22
12. Llewellyn A, Stowe ZN. Psychotropic medications in lactation. J Clin Psychiatry 1998;59(suppl 2)41-52
13. Moretti ME, Koren G, Verjee Z, et al. Monitoring lithium in breast milk: an individualized approach for breast-feeding mothers. Ther Drug Monit 2003;25:364-366
14. Birnbaum CS, Cohen LS, Bailey JW, et al. Serum concentrations of antidepressants and benzodiazepines in nursing infants: a case series. Pediatrics 1999;104. Available at: http://www.pediatrics.org/cgi/content/full/ 104/1/e11. Accessed June 10, 2006
15. Schmidt K, Olesen OV, Jensen PN. Citalopram and breast-feeding: serum concentration and side effects in the infant. Biol Psychiatry 2000;47:164-165
16. Kraepelin E. Manic-Depressive Insanity and Paranoia. Edinburgh, Scotland: Livingstone; 1921
17. Bratfos O, Haug JO. Puerperal mental disorders in manic-depressive females. Acta Psychiatr Scand 1966;42:285-294
18. Reich T, Winokur G. Postpartum psychoses in patients with manic depressive disease J Nerv Ment Dis 1970;151:60-68
19. Brockington IF, Cernik KF, Schofield EM, et al. Puerperal psychosis: phenomena and diagnosis. Arch Gen Psychiatry 1981;38:829-833
20. Davidson J, Robertson E. A follow-up study of post partum illness, 1946-1978. Acta Psychiatr Scand 1985;71:451-457
21. Klompenhouwer JL, van Hulst AM. Classification of postpartum psychosis: a study of 250 mother and baby admissions in The Netherlands. Acta Psychiatr Scand 1991;84:255-267
22. Rhode A, Marneros A. Postpartum psychoses: onset and long-term course. Psychopathology 1993;26:203-209
23. Blehar MC. Gender differences in risk factors for mood and anxiety disorders: implications for clinical treatment research. Psychopharmacol Bull 1995;31:687-691
24. Freeman MP. Omega-3 fatty acids in psychiatry: a review. Ann Clin Psychiatry 2000;12:159-165
25. Viguera AC, Nonacs R, Cohen LS, et al. Risk of recurrence of bipolar disorder in pregnant and nonpregnant women after discontinuing lithium maintenance. Am J Psychiatry 2000;157:179-184
26. Wisner KL, Hanusa BH, Peindl KS, et al. Prevention of postpartum episodes in women with bipolar disorder. Biol Psychiatry 2004;56:592-596
27. Kurshan N, Epperson NC. Oral contraceptives and mood in women with and without premenstrual dysphoria: a theoretical model. Arch Womens Ment Health 2006;9:1-14
28. Douma SL, Husband C, O'Donnell ME, et al. Estrogen-related mood disorders: reproductive life cycle factors. ANS Adv Nurs Sci 2005;28:364-375
29. Reglan (metoclopramide). Physicians' Desk Reference. 60th ed. Montvale, NJ: Thomson PDR; 2006:2599
30. Reynolds F, Knott C. Pharmacokinetics in pregnancy and placental drug transfer. Oxf Rev Reprod Biol 1989;11:389-449
31. Hendrick V, Stowe ZN, Altshuler LL, et al. Placental passage of antidepressant medications. Am J Psychiatry 2003;160:993-996
32. Newport DJ, Viguera AC, Beach AJ, et al. Lithium placental passage and obstetrical outcome: implications for clinical management during late pregnancy. Am J Psychiatry 2005;162:2162-2170
33. Myllynen PK, Pienimaki PK, Vahakangas KH. Transplacental passage of lamotrigine in a human placental perfusion system in vitro and in maternal and cord blood in vivo. Eur J Clin Pharmacol 2003;58:677-682
34. Pennell PB, Newport DJ, Stowe ZN, et al. The impact of pregnancy and childbirth on the metabolism of lamotrigine. Neurology 2004;62:292-295
35. Kristensen JH, Ilett KF, Hackett LP, et al. Distribution and excretion of fluoxetine and norfluoxetine in human milk. Br J Clin Pharmacol 1999;48:521-527
36. Wright S, Dawling S, Ashford JJ. Excretion of fluvoxamine in breast milk [letter]. Br J Clin Pharmacol 1991;31:209
37. Spigset O, Carleborg L, Ohman R, et al. Excretion of citalopram in breast milk. Br J Clin Pharmacol 1997;44:295-298
38. Öhman I, Vitols S, Tomson T. Lamotrigine in pregnancy: pharmacokinetics during delivery, in neonate, and during lactation. Epilepsia 2000;41:709-713
39. Gardiner SJ, Kristensen JH, Begg EJ, et al. Transfer of olanzapine into breast milk, calculation of infant drug dose, and effect on breast-fed infant. Am J Psychiatry 2003;160:1428-1431
40. Heikkinen T, Ekblad U, Kero P, et al. Citalopram in pregnancy and lactation. Clin Pharmacol Ther 2002;72:184-191
41. Yoshida K, Smith B, Kumar RC. Fluvoxamine in breast milk and infant development [letter]. Br J Clin Pharmacol 1997;44:209-213
42. Stowe ZN, Owens MJ, Landry JC, et al. Sertraline and desmethylsertraIine in human breast milk and nursing infants. Am J Psychiatry 1997;154:1255-1260
43. Stowe ZN, Cohen LS, Hostetter A, et al. Paroxetine in human breast milk and nursing infants. Am J Psychiatry 2000;157:185-189
44. Suri R, Stowe ZN, Hendrick V, et al. Estimates of nursing infant daily dose of fluoxetine through breast milk. Biol Psychiatry 2002;52:446-451
45. Taddio A, Ito S, Koren G. Excretion of fluoxetine and its metabolite, norfluoxetine, in human breast milk. J Clin Pharmacol 1996;36:42-47
46. Bennett PN. Use of Monographs on Drugs. In: Bennett PN, ed. Drugs and Human Lactation. 2nd ed. Amsterdam: Elsevier; 1996:67-74
47. Hendrick V, Smith LM, Hwang S, et al. Weight gain in breastfed infants of mothers taking antidepressant medications. J Clin Psychiatry 2003;64:410-412
48. Newport DJ, Stowe ZN, Nemeroff CB. Parental depression: animal models of an adverse life event. Am J Psychiatry 2002;159:1265-1283
49. Essex MJ, Klein MH, Cho E, et al. Maternal stress beginning in infancy may sensitize children to later stress exposure: effects on Cortisol and behavior. Biol Psychiatry 2002;52:776-784
50. Mäki P, Veijola J, Rasanen R, et al. Criminality in the offspring of antenatally depressed mothers: a 33-year follow-up of the Northern Finland 1966 Birth Cohort. J Affect Disord 2003;74:273-278
51. Weissman MM, Pilowsky DJ, Wickramaratne PJ, et al, for the STAR*D-Child Team. Remissions in maternal depression and child psychopathology: a STAR*D-child report. JAMA 2006;295:1389-1398
52. Ragan K, Stowe ZN, Newport DJ. The use of antidepressants and mood stabilizers in breast feeding women. In: Cohen LS, Nonacs RM, eds. Mood and Anxiety Disorders During Pregnancy and Postpartum. Washington, DC: American Psychiatric Publishing; 2005:105-144
53. Chaudron LH, Jefferson JW. Mood stabilizers during breastfeeding: a review. J Clin Psychiatry 2000;61:79-90
54. Llewellyn A, Stowe ZN, Strader JR Jr. The use of lithium and management of women with bipolar disorder during pregnancy and lactation. J Clin Psychiatry 1998;59(suppl 6):57-64
55. Stahl MM, Neiderud J, Vinge E. Thrombocytopenic purpura and anemia in a breast-fed infant whose mother was treated with valproic acid. J Pediatr 1997;130:1001-1003
56. Hill RC, McIvor RJ, Wojnar-Horton RE, et al. Risperidone distribution and excretion into human milk: case report and estimated infant exposure during breast-feeding [letter]. J Clin Psychopharmacol 2000;20:285-286
57. Tomson T, Öhman I, Vitols S. Lamotrigine in pregnancy and lactation: a case report. Epilepsia 1997;38:1039-1041
58. Rambeck B, Kurlemann G, Stodieck SR, et al. Concentrations of lamotrigine in a mother on lamotrigine treatment and her newborn child. Eur J Clin Pharmacol 1997;51:481-484
59. Liporace J, Kao A, D'Abreu A. Concerns regarding lamotrigine and breast feeding. Epilepsy Behav 2004;5:102-105
60. Bulau P, Paar WD, von Unruh GE. Pharmacokinetics of oxcarbazepine in the newborn child of an oxcarbazepine-treated mother. Eur J Clin Pharmacol 1988;34:311-313
61. Öhman I, Vitols S, Luef G, et al. Topiramate kinetics during delivery, lactation, and in the neonate: preliminary observations. Epilepsia 2002;43:1157-1160
62. Barnas C, Rossmann M, Roessler H, et al. Benzodiazepines and other psychotropic drugs abused by patients in a methadone maintenance program: familiarity and preference. J Clin Psychopharmacol 1992;12:397-402
63. Goldstein DJ, Corbin LA, Fung MC. Olanzapine-exposed pregnancies and lactation: early experience. J Clin Psychopharmacol 2000;20:399-403
64. Kirchheiner J, Berghofer A, Bolk-Weischedel D. Healthy outcome under olanzapine treatment in a pregnant woman. Pharmacopsychiatry 2000;33:78-80
65. Croke S, Buist A, Hackett LP, et al. Olanzapine excretion in human breast milk: estimation of infant exposure. Int J Neuropsychopharmacol 2002;5:243-247
66. Friedman SH, Rosenthal MB. Treatment of perinatal delusional disorder: a case report. Int J Psychiatry Med 2003;33:391-394
67. Ambresin G, Berney P, Schulz P, et al. Olanzapine excretion into breast milk: a case report. J Clin Psychopharmacol 2004;24:93-95
68. Lee A, Geisbrecht E, Dunn E, et al. Excretion of quetiapine in breast milk [letter]. Am J Psychiatry 2004;161:1715-1716
69. Misri S, Corral M, Wardrop AA, et al. Quetiapine augmentation in lactation: a series of case reports. J Clin Psychopharmacol 2006;26:508-511
70. Ratnayake T, Libretto SE. No complications with risperidone treatment before and throughout pregnancy and during the nursing period [letter]. J Clin Psychiatry 2002;63:76-77
71. Ilett KF, Hacket LP, Kristensen JH, et al. Transfer of risperidone and 9-hydroxyrisperidone into human milk. Ann Pharmacother 2004;38:273-276
72. Cunnington M, Tennis P, for the International Lamotrigine Pregnancy Registry Scientific Advisory Committee. Lamotrigine and the risk of malformations in pregnancy. Neurology 2005;64:955-960
73. DeVane CL, Stowe ZN, Donovan JL, et al. Therapeutic drug monitoring of psychoactive drugs during pregnancy in the genomic era: challenges and opportunities. J Psychopharmacol 2006;20(suppl 4):54-59